Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00496080 · ClinicalTrials.gov registry record · NA
Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding
A NA study, sponsored by Ethicon.
- Terminated
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT00496080 is a NA study that was terminated before completion, run by Ethicon. The registered enrollment target is 87 participants.
The verdict
NCT00496080, a NA study, was terminated before completion, sponsored by Ethicon.
- TERMINATED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and effectiveness of Doppler guided uterine artery occlusion (D-UAO) for the reduction of fibroid associated bleeding.
Interventions
- DEVICE Doppler-Guided Uterine Artery Occlusion Device (DUAO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00496080
The ClinicalTrials.gov registry entry for NCT00496080 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Doppler-Guided Uterine Artery Occlusion Device (DUAO) is the first listed.
NCT00496080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00496080 about?
NCT00496080 is a clinical study titled "Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding". The objective of this study is to evaluate the safety and effectiveness of Doppler guided uterine artery occlusion (D-UAO) for the reduction of fibroid associated bleeding.
What is the current status of trial NCT00496080?
This trial is currently terminated. It is a NA study. The enrollment target is 87 participants. The study started on 2007-06. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00496080?
The interventions under investigation include: Doppler-Guided Uterine Artery Occlusion Device (DUAO) (DEVICE).
Who is sponsoring clinical trial NCT00496080?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.